GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (OTCPK:NUVOQ) » Definitions » Buildings And Improvements

NUVOQ (Holdco Nuvo Group DG) Buildings And Improvements : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG Buildings And Improvements?


Holdco Nuvo Group DG Buildings And Improvements Historical Data

The historical data trend for Holdco Nuvo Group DG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG Buildings And Improvements Chart

Holdco Nuvo Group DG Annual Data
Trend Dec21 Dec22 Dec23
Buildings And Improvements
- - -

Holdco Nuvo Group DG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Buildings And Improvements - - - - -

Holdco Nuvo Group DG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Holdco Nuvo Group DG Business Description

Traded in Other Exchanges
N/A
Address
94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155
Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.